Finance

Lists
1CO1:FRA
Covestro ADR
€29.60
-3.27%
(-1.00) 1D
Aug 3, 8:07:45 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1CO1...
Open
€29.60
High
€29.60
Low
€29.60
Mkt. cap
12.60B
Avg. vol.
0.00
Volume
0.00
52-wk high
€30.00
52-wk low
€26.80
No. of employees
18K
Open
€29.60
High
€29.60
Low
€29.60
Mkt. cap
12.60B
Avg. vol.
0.00
Volume
0.00
52-wk high
€30.00
52-wk low
€26.80
No. of employees
18K
News stories
From sources across the web
Profile
Covestro AG is a German company producing polyurethane and polycarbonate raw materials. Products include isocyanates and polyols for cellular foams, thermoplastic polyurethane and polycarbonate pellets, as well as polyurethane based additives used in the formulation of coatings and adhesives. It is a Bayer spin-off formed in the fall of 2015 and was formerly called Bayer MaterialScience. The main industries served are automotive manufacturing and supply, electrical engineering and electronics, construction and home products, and sports and leisure. Their products include coatings and adhesives, polyurethanes that are used in thermal insulation, electrical housings, and as a component of footwear and mattresses, and polycarbonates such as Covestro's Makrolon, which are highly impact-resistant plastics. Covestro polyurethane was used in the 2014 official FIFA World Cup football. Before 2019, Covestro enjoyed rapid earnings growth following supply shortages of chemicals used in foams. Covestro shares were first offered on the Frankfurt Stock Exchange in October 2015. Bayer sold its entire remaining stake in May 2018, Bayer's pension fund had a 6.8% stake managed separately. Wikipedia
About Covestro ADR
CEOMarkus Steilemann
Employees17.8K
FoundedSep 1, 2015
HeadquartersLeverkusen, North Rhine-Westphalia, Germany
SectorSpeciality chemicals
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.17B
2.92B
-
-
Cost of goods sold
2.68B
2.54B
-
-
Cost of revenue
2.68B
2.54B
-
-
Research and development expenses
81.00M
85.00M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
437.00M
454.00M
-
-
Operating expense
463.00M
575.00M
-
-
Total operating expenses
3.15B
3.12B
-
-
Operating income
25.00M
-205.00M
-
-
Other non operating income
-5.00M
18.00M
-
-
EBT including unusual items
-9.00M
-353.00M
-
-
EBT excluding unusual items
-9.00M
-223.00M
-
-
Income tax expense
37.00M
24.00M
-
-
Effective tax rate
-411.11%
-6.80%
-
-
Other operating expenses
-55.00M
36.00M
-
-
Net income
-47.00M
-378.00M
-
-
Net profit margin
-1.48%
-12.97%
1.78%
1.78%
Earnings per share
-0.25
-
-
-
Interest and investment income
9.00M
10.00M
-
-
Interest expense
-33.00M
-44.00M
-
-
Net interest expenses
-24.00M
-34.00M
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
242.00M
-39.25M
-
-
Gain or loss from assets sale
-25.00M
-30.00M
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps